Document Type

Article

Publication Date

8-20-2013

Publication Title

Proceedings of the National Academy of Sciences of the United States of America

Abstract

Communication about prescription drugs ought to be a paragon of public science communication. Unfortunately, it is not. Consumers see $4 billion of direct-to-consumer advertising annually, which typically fails to present data about how well drugs work. The professional label—the Food and Drug Administration's (FDA) mechanism to get physicians information needed for appropriate prescribing—may also fail to present benefit data. FDA labeling guidance, in fact, suggests that industry omit bene

DOI

10.1073/pnas.1214646110

Share

COinS